Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
Provided By GlobeNewswire
Last update: May 29, 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 11:05 a.m. ET in New York, NY.
Read more at globenewswire.comNASDAQ:CABA (6/2/2025, 11:47:00 AM)
2.03
+0.16 (+8.56%)
Find more stocks in the Stock Screener
CABA Latest News and Analysis
17 days ago - ChartmillTop movers in Friday's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
18 days ago - ChartmillThese stocks are gapping in today's sessionTraders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
